Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.39B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 3 |
Citigroup
C
|
+$429M |
| 4 |
United States Oil Fund
USO
|
+$386M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$378M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$946M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$771M |
| 3 |
Alibaba
BABA
|
+$626M |
| 4 |
Tesla
TSLA
|
+$505M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$421M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.04% |
| 2 | Technology | 2.01% |
| 3 | Communication Services | 1.39% |
| 4 | Financials | 0.98% |
| 5 | Consumer Discretionary | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
PUT
Factset
FDS
$10.8B
| $6.41M | ﹤0.01% |
24,600
-23,800
| -49% | -$6.48M |
|
2227
Guardant Health
GH
$22.6B
| $6.41M | ﹤0.01% |
92,096
-81,310
| -47% | -$6.24M |
|
2228
CALL
Melco Resorts & Entertainment
MLCO
$1.97B
| $6.41M | ﹤0.01% |
516,900
+154,800
| +43% | +$2.96M |
|
2229
Fox Class A
FOXA
$28.3B
| $6.41M | ﹤0.01% |
271,224
+62,296
| +30% | +$2.05M |
|
2230
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.83B
| $6.41M | ﹤0.01% |
75,817
+57,045
| +304% | +$5.53M |
|
2231
PUT
Inovio Pharmaceuticals
INO
$130M
| $6.41M | ﹤0.01% |
71,767
+69,775
| +3,503% | +$4.3M |
|
2232
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| $6.4M | ﹤0.01% |
51,848
-80,805
| -61% | -$10.3M |
|
2233
PUT
Synaptics
SYNA
$3.82B
| $6.4M | ﹤0.01% |
110,600
-22,600
| -17% | -$1.53M |
|
|
CIM
2234
PUT
Chimera Investment
CIM
$964M
| $6.4M | ﹤0.01% |
234,400
+209,633
| +846% | +$11.9M |
|
2235
Roper Technologies
ROP
$41.8B
| $6.4M | ﹤0.01% |
20,521
-5,631
| -22% | -$2M |
|
2236
PUT
Alpha Pro Tech
APT
$55.8M
| $6.4M | ﹤0.01% |
+529,500
| New | +$4.42M |
|
2237
CALL
NewMarket
NEU
$8.49B
| $6.39M | ﹤0.01% |
16,700
+3,000
| +22% | +$1.27M |
|
|
NUVA
2238
CALL
DELISTED
NuVasive, Inc.
NUVA
| $6.39M | ﹤0.01% |
126,200
+65,200
| +107% | +$4.37M |
|
2239
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.4B
| $6.39M | ﹤0.01% |
132,001
+127,584
| +2,888% | +$8.27M |
|
2240
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$720M
| $6.39M | ﹤0.01% |
14,165
-11,920
| -46% | -$10.8M |
|
2241
PUT
Qiagen
QGEN
$9.03B
| $6.38M | ﹤0.01% |
144,665
+34,705
| +32% | +$1.36M |
|
|
MNDT
2242
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $6.38M | ﹤0.01% |
602,959
-230,001
| -28% | -$3.31M |
|
2243
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
| $6.37M | ﹤0.01% |
135,688
-13,992
| -9% | -$755K |
|
2244
Kinross Gold
KGC
$38.6B
| $6.36M | ﹤0.01% |
1,598,546
-860,116
| -35% | -$4.16M |
|
|
CLVS
2245
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.36M | ﹤0.01% |
1,000,146
+966,111
| +2,839% | +$7.75M |
|
|
APHA
2246
CALL
DELISTED
Aphria Inc. Common Shares
APHA
| $6.36M | ﹤0.01% |
2,077,500
-906,000
| -30% | -$3.62M |
|
2247
PUT
Jabil
JBL
$32.7B
| $6.36M | ﹤0.01% |
258,600
+189,900
| +276% | +$6.62M |
|
2248
FTI Consulting
FCN
$4.2B
| $6.35M | ﹤0.01% |
53,023
-46,513
| -47% | -$5.47M |
|
2249
CALL
Vodafone
VOD
$36.7B
| $6.35M | ﹤0.01% |
461,200
-439,100
| -49% | -$7.84M |
|
2250
CALL
Fiverr
FVRR
$338M
| $6.34M | ﹤0.01% |
+251,800
| New | +$6.77M |
|
Similar funds
Jeff Yass's Q1 2020 Portfolio in Review
As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q1 2020 filing shows 1,843 new, 4,539 increased, 3,686 reduced and 1,300 closed positions. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M. The largest sale was Amazon, an estimated $946M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 89% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
- Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
- Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
- Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
- Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
- Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.